Reyes, C. ., Newby, D. ., Raventós, B. ., Verhamme, K. ., Mosseveld, M. ., Prieto-Alhambra, D. ., … Duarte-Salles, T. . (2024). Trends of use and characterisation of anti-dementia drugs users: a large multinational-network population-based study. Age Ageing, 53. http://doi.org/10.1093/ageing/afae106
K. Verhamme
First name
K.
Last name
Verhamme
Raventós, B. ., Català, M. ., Du, M. ., Guo, Y. ., Black, A. ., Inberg, G. ., … Burn, E. . (2023). IncidencePrevalence: An R package to calculate population-level incidence rates and prevalence using the OMOP common data model. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5717
Li, X. ., Burn, E. ., Duarte-Salles, T. ., Yin, C. ., Reich, C. ., Delmestri, A. ., … Prieto-Alhambra, D. . (2022). Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US. Bmj, 379, e071594. http://doi.org/10.1136/bmj-2022-071594
Burn, E. ., Li, X. ., Kostka, K. ., Stewart, H. M., Reich, C. ., Seager, S. ., … Prieto-Alhambra, D. . (2022). Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries. Pharmacoepidemiol Drug Saf, 31, 495–510. http://doi.org/10.1002/pds.5419
Li, X. ., Ostropolets, A. ., Makadia, R. ., Shoaibi, A. ., Rao, A. ., Sena, A. G., … Prieto-Alhambra, D. . (2021). Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study. BMJ. http://doi.org/10.1136/bmj.n1435